6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-5-methyl-N-((6-methyl-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)methyl)benzofuran-4-carboxamide

ID: ALA4162406

Chembl Id: CHEMBL4162406

PubChem CID: 145962295

Max Phase: Preclinical

Molecular Formula: C25H28F3N3O4

Molecular Weight: 491.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(c1cc2occc2c(C(=O)NCc2c(C(F)(F)F)cc(C)[nH]c2=O)c1C)C1CCOCC1

Standard InChI:  InChI=1S/C25H28F3N3O4/c1-4-31(16-5-8-34-9-6-16)20-12-21-17(7-10-35-21)22(15(20)3)24(33)29-13-18-19(25(26,27)28)11-14(2)30-23(18)32/h7,10-12,16H,4-6,8-9,13H2,1-3H3,(H,29,33)(H,30,32)

Standard InChI Key:  JFONWYWBVOYASL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4162406

    ---

Associated Targets(Human)

Pfeiffer (261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EZH1 Tchem EZH1/SUZ12/EED/AEBP2/RBBP4 complex (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 491.51Molecular Weight (Monoisotopic): 491.2032AlogP: 4.69#Rotatable Bonds: 6
Polar Surface Area: 87.57Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.27CX Basic pKa: 3.43CX LogP: 2.61CX LogD: 2.61
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.52Np Likeness Score: -0.86

References

1. Lu B, Shen X, Zhang L, Liu D, Zhang C, Cao J, Shen R, Zhang J, Wang D, Wan H, Xu Z, Ho MH, Zhang M, Zhang L, He F, Tao W..  (2018)  Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma.,  (2): [PMID:29456795] [10.1021/acsmedchemlett.7b00437]

Source